Skip to main content
OpenTrials
Completed

NCT Number: NCT03371069

Use of Methylphenidate in Children and Adolescents in France

The use of methylphenidate in children and adolescents in France from 2010 to 2015

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Robert Debré, APHP

Paris, 75019, France

About this study

To describe the use of methylphenidate in children and adolescents in France from 2010 to 2015

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • children and adolescents (0-17 years)
  • registered in the French Health Insurance Database from 2012-2015

Treatment and study plan

users of methylphenidate

Other

Children and adolescents who are users of methylphenidate, 2010 to 2015

Primary outcomes

  1. use of methylphenidate over time

    Time frame: 6 years

    Describe of the use of methylphenidate over time to determine the impact of regulatory information of appropriate prescription conditions of use in September 2012

Secondary outcomes

  1. Describe methylphenidate patterns of use over time

    Time frame: 6 years

    Pharmaceutical specialties (immediate or extended release forms) prescribed by type of delivery: initial or renewals.

    Profile of prescribers: hospital or private practice (general practitioners, specialists) depending on type of prescription (initial or renewal); geographical distribution of the prescribers Profile of patients: sex, average age and age classes (0-23 months, 2-5 years, 6-11 years, 12-17 years), socioeconomic status, long-lasting diseases status for psychosis, severe personality disorder, mental retardation.

    Pattern of methylphenidate use: duration of treatment, prolonged use, interruption of treatment.

  2. Co-prescription of methylphenidate and non-psychostimulant psychotropic drugs

    Time frame: 6 years

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Dec 13, 2017
Registry last updated
Dec 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.